Visual Presentation and Factors Affecting Visual Outcome in Children with Craniopharyngioma in East Coast States of Peninsular Malaysia: A Five-year Review.
pediatric craniopharyngioma . visual presentation . final visual outcome
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
08 Apr 2019
08 Apr 2019
Historique:
entrez:
18
6
2019
pubmed:
18
6
2019
medline:
18
6
2019
Statut:
epublish
Résumé
Purpose To describe the visual presentation and factors affecting visual outcome in pediatric patients treated for craniopharyngioma at a referral center in the East Coast states of Peninsular Malaysia. Methodology A retrospective review of medical records of children aged 17 years and below who had been treated for craniopharyngioma in Hospital Universiti Sains Malaysia from January 2014 to December 2018. The data collected included age, gender, presenting symptoms and duration, visual acuity, visual fields, color vision, light brightness, relative afferent pupillary defects, fundus examination and cranial nerves examination. The best corrected visual acuity during presentation, and after a one-year post-operative period, was documented. Records on investigations, surgical procedures, therapeutic modalities and recurrences were also reviewed. Results A total of 11 pediatric patients (22 eyes) were recruited. Fifty percent presented with optic atrophy. The mean duration of the onset of symptoms before consultation was 22.3 (24.5) months. A final best corrected visual acuity of 6/12 (20/40) or better was observed in 50% of the patients. There was a statistically significant association between presenting visual acuity, optic nerve function and visual field defects, and the final visual outcome. Conclusions Visual presentations in our study were fairly similar to previous reported studies. One-third presented late with permanent visual loss. Almost half had significant visual impairment after one-year post-operative period. Significant associations were observed between presenting visual acuity, duration of symptoms, impairment of optic nerve function tests, and visual field defects during presentation, and final visual acuity at one year after treatment.
Identifiants
pubmed: 31205829
doi: 10.7759/cureus.4407
pmc: PMC6561515
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e4407Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Exp Ophthalmol. 2003 Jun;31(3):220-8
pubmed: 12786772
Endocr Rev. 2006 Jun;27(4):371-97
pubmed: 16543382
J Neurosurg. 2007 Jan;106(1 Suppl):3-12
pubmed: 17233305
Childs Nerv Syst. 2010 Aug;26(8):1029-34
pubmed: 20349186
Pediatr Neurosurg. 2010;46(3):205-12
pubmed: 20962554
J Pediatr Ophthalmol Strabismus. 2012 Jan-Feb;49(1):38-42
pubmed: 21323242
Can J Ophthalmol. 2013 Dec;48(6):494-9
pubmed: 24314410
J Neurooncol. 2014 Dec;120(3):651-6
pubmed: 25173232
Ophthalmology. 1989 Feb;96(2):195-9
pubmed: 2704538
Neuroophthalmology. 2015 Jun 17;39(3):132-139
pubmed: 27928346
Brain Tumor Res Treat. 2017 Apr;5(1):16-23
pubmed: 28516074
Acta Ophthalmol. 2018 Feb;96(1):39-45
pubmed: 28661562
J Neurooncol. 2018 May;137(3):645-651
pubmed: 29344823
Pediatr Neurosurg. 1996 Nov;25(5):240-6; discussion 247
pubmed: 9309787
J Neurosurg. 1998 Oct;89(4):547-51
pubmed: 9761047